Enterprise Therapeutics

company

About

A UK-based developer of drugs to treat respiratory diseases

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
£29M
Industries
Health Care,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.

In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£29M
Enterprise Therapeutics has raised a total of £29M in funding over 2 rounds. Their latest funding was raised on Apr 12, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 12, 2018 Series B £29M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Enterprise Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series B